ArticleOncoimmunology2013

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer.

Ben C Creelan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.